Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
Panax ginseng and Panax notoginseng, two well-known herbs with enormous medical value in Asian countries, have a long usage history in China for the therapy of some diseases, such as stroke. Ginsenoside Rb1 is one of most important active ingredients in Panax ginseng and Panax notoginseng. In the la...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_5ad43e3d062a49c687d4583537dfb8b0 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Liang Gong |e author |
| 700 | 1 | 0 | |a Jiayi Yin |e author |
| 700 | 1 | 0 | |a Yu Zhang |e author |
| 700 | 1 | 0 | |a Ren Huang |e author |
| 700 | 1 | 0 | |a Yuxuan Lou |e author |
| 700 | 1 | 0 | |a Haojie Jiang |e author |
| 700 | 1 | 0 | |a Liyan Sun |e author |
| 700 | 1 | 0 | |a Jinjing Jia |e author |
| 700 | 1 | 0 | |a Xiansi Zeng |e author |
| 245 | 0 | 0 | |a Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases |
| 260 | |b Frontiers Media S.A., |c 2022-06-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2022.914352 | ||
| 520 | |a Panax ginseng and Panax notoginseng, two well-known herbs with enormous medical value in Asian countries, have a long usage history in China for the therapy of some diseases, such as stroke. Ginsenoside Rb1 is one of most important active ingredients in Panax ginseng and Panax notoginseng. In the last two decades, more attention has focused on ginsenoside Rb1 as an antioxidative, anti-apoptotic and anti-inflammatory agent that can protect the nervous system. In the review, we summarize the neuroprotective roles of ginsenoside Rb1 and its potential mechanisms in central nervous system diseases (CNSDs), including neurodegenerative diseases, cerebral ischemia injury, depression and spinal cord injury. In conclusion, ginsenoside Rb1 has a potential neuroprotection due to its inhibition of oxidative stress, apoptosis, neuroinflammation and autophagy in CNSDs and may be a promising candidate agent for clinical therapy of CNSDs in the future. | ||
| 546 | |a EN | ||
| 690 | |a central nervous system diseases | ||
| 690 | |a ginsenoside Rb1 | ||
| 690 | |a neuroprotection | ||
| 690 | |a mechanisms | ||
| 690 | |a antioxidant | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 13 (2022) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2022.914352/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/5ad43e3d062a49c687d4583537dfb8b0 |z Connect to this object online. |